Biomarkers Expand Precision in CRC

Emerging biomarkers guide colorectal cancer diagnosis, stratification, and treatment selection

1

Biomarkers are transforming colorectal cancer management by guiding diagnosis, risk stratification, and therapy selection.
2

Established biomarkers like KRAS/NRAS and BRAF mutations are essential for personalized treatment in colorectal cancer.
3

Emerging noninvasive biomarkers, including ctDNA and microbiome analysis, enhance early detection and screening for colorectal cancer.
4

Multi-omics integration is crucial for developing robust prognostic models that improve risk stratification in colorectal cancer.
5

Future advancements in colorectal cancer biomarkers will focus on validation, standardization, and personalized treatment strategies.

1